VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,978 | -29.3% | 300,000 | 0.0% | 0.17% | -1.7% |
| Q2 2023 | $5,625 | +30.0% | 300,000 | 0.0% | 0.17% | -32.3% |
| Q1 2023 | $4,326 | -25.5% | 300,000 | 0.0% | 0.26% | -20.7% |
| Q4 2022 | $5,805 | -100.0% | 300,000 | -25.0% | 0.32% | -44.7% |
| Q3 2022 | $13,740,000 | +124.8% | 400,000 | 0.0% | 0.59% | +79.8% |
| Q2 2022 | $6,112,000 | -33.0% | 400,000 | 0.0% | 0.33% | -14.7% |
| Q1 2022 | $9,128,000 | -38.1% | 400,000 | 0.0% | 0.38% | -4.5% |
| Q4 2021 | $14,748,000 | -21.6% | 400,000 | 0.0% | 0.40% | -5.0% |
| Q3 2021 | $18,800,000 | -37.6% | 400,000 | -20.0% | 0.42% | -31.1% |
| Q2 2021 | $30,125,000 | – | 500,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |